Institute of Experimental Pharmacology and Toxicology, The Slovak Academy of Sciences, Slovakia
Received date: April 22, 2016; Accepted date: April 25, 2016; Published date: April 28, 2016
Citation: Durisova M (2016) Opinion: Journal of Drug Metabolism and Toxicology. J Drug Metab Toxicol 7:e128. doi:10472/2157-7609.1000e128
Copyright: © 2016 Durisova M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,distribution, and reproduction in any medium, provided the original author and source are credited.
Visit for more related articles at Journal of Drug Metabolism & Toxicology
The field of pharmacokinetics still faces considerable scientific challenges especially in the areas of drug metabolism and toxicology.
Therefore, several new methods have gradually emerged in pharmacokinetics, including new methods for mathematical modeling, and the development of mathematical models has become one of the most rapidly growing and exciting application-oriented sub-discipline of pharmacokinetics, especially in studies of drug metabolism and toxicity.
While recent years brought a tremendous progress in the understanding of drug metabolism and toxicity many unresolved issues and questions remain. Therefore, editor hopes that articles published in the Journal of Drug Metabolism & Toxicology will prompt scientists to solve difficult questions related to drug metabolism and toxicity.
The reviewer worked as a researcher and contractor in the 6FPProject “Network of Excellence: Biosimulation - A New Tool in Drug Development, contract No. LSHB CT-2004-005137” and in the 7FPProject “Network of Excellence: Virtual Physiological Human”. The reviewer worked also in several previous COST program actions.
At present, the reviewer precipitates: 1) In the Action BM1204 of the COST program entitled: An integrated European platform for pancreas cancer research: from basic science to clinical and public health interventions for a rare disease; and 2) In the EuroNanoMed2, an integrated European project.